FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

9/5/2018
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   9/5/2018     P    2000   A $0.0476   25857198   D    
Common Stock   9/5/2018     P    3000   A $0.0476   25860198   D    
Common Stock   9/5/2018     P    1000   A $0.0476   25861198   D    
Common Stock   9/5/2018     P    2000   A $0.0476   25863198   D    
Common Stock   9/5/2018     P    1000   A $0.0491   25864198   D    
Common Stock   9/5/2018     P    1000   A $0.0491   25865198   D    
Common Stock   9/5/2018     P    1000   A $0.0474   25866198   D    
Common Stock   9/5/2018     P    2000   A $0.0473   25868198   D    
Common Stock   9/5/2018     P    1000   A $0.0473   25869198   D    
Common Stock   9/5/2018     P    1000   A $0.0478   25870198   D    
Common Stock   9/5/2018     P    1000   A $0.0476   25871198   D    
Common Stock   9/5/2018     P    1000   A $0.0476   25872198   D    
Common Stock   9/5/2018     P    1000   A $0.0481   25873198   D    
Common Stock   9/5/2018     P    1000   A $0.0475   25874198   D    
Common Stock   9/5/2018     P    1000   A $0.0477   25875198   D    
Common Stock   9/5/2018     P    1000   A $0.0475   25876198   D    
Common Stock   9/6/2018     P    1000   A $0.0468   25777198   D    
Common Stock   9/6/2018     P    1000   A $0.0451   25878198   D    
Common Stock   9/6/2018     P    1000   A $0.0451   25879198   D    
Common Stock   9/6/2018     P    1000   A $0.0388   25880198   D    
Common Stock   9/6/2018     P    1000   A $0.0386   25881198   D    
Common Stock   9/6/2018     P    1000   A $0.0389   25882198   D    
Common Stock   9/6/2018     P    1000   A $0.0392   25883198   D    
Common Stock   9/6/2018     P    2000   A $0.0391   25885198   D    
Common Stock   9/6/2018     P    3000   A $0.0391   25888198   D    
Common Stock   9/6/2018     P    500   A $0.039   25888698   D    
Common Stock   9/6/2018     P    1000   A $0.0386   25889698   D    
Common Stock   9/6/2018     P    2000   A $0.0386   25891698   D    
Common Stock   9/6/2018     P    500   A $0.0386   25892198   D    
Common Stock   9/6/2018     P    1000   A $0.0398   25893198   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
X President

Signatures
Michael Scott Mann 9/10/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.